ARS Pharmaceuticals, Inc. (SPRY) — Institutional Holders, Q2 2026 (page 3)
208 institutional investment managers reported a SPRY position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $725.6M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 201 to 208. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
SPRY 13F holders ranked 201–208 of 208
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 201 | Keating Financial Advisory Services#201 · 5 sh | 5 | $40.00 | 0.00% | 0.0% |
| 202 | GHP Investment Advisors#202 · 3 sh | 3 | $25.00 | — | 0.0% |
| 203 | Wealth Enhancement Services#203 · 2 sh | 2 | $16.00 | — | New |
| 204 | SJS Investment Consulting#204 · 1 sh | 1 | $9.00 | — | New |
| 205 | Hughes Financial Services#205 · 1 sh | 1 | $8.00 | 0.00% | New |
| 206 | NBC SECURITIES#206 · 1 sh | 1 | $8.00 | — | 0.0% |
| 207 | Covestor Ltd#207 · 46 sh | 46 | $0.00 | 0.00% | +557.1% |
| 208 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#208 · 46,123 sh | 46,123 | — | — | -14.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.